IS5691A - Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva - Google Patents

Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva

Info

Publication number
IS5691A
IS5691A IS5691A IS5691A IS5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A IS 5691 A IS5691 A IS 5691A
Authority
IS
Iceland
Prior art keywords
treatment
ghs
serm
selective
growth hormone
Prior art date
Application number
IS5691A
Other languages
English (en)
Icelandic (is)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products, Inc. filed Critical Pfizer Products, Inc.
Publication of IS5691A publication Critical patent/IS5691A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5691A 1998-06-16 2000-10-27 Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva IS5691A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5691A true IS5691A (is) 2000-10-27

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5691A IS5691A (is) 1998-06-16 2000-10-27 Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva

Country Status (30)

Country Link
EP (1) EP1087764A1 (hr)
JP (1) JP2002518326A (hr)
KR (1) KR20010052852A (hr)
CN (1) CN1301160A (hr)
AP (1) AP9901582A0 (hr)
AR (1) AR018869A1 (hr)
AU (1) AU4054799A (hr)
BG (1) BG105041A (hr)
BR (1) BR9911324A (hr)
CA (1) CA2335134A1 (hr)
CO (1) CO5070587A1 (hr)
EA (1) EA200001186A1 (hr)
GT (1) GT199900087A (hr)
HN (1) HN1999000097A (hr)
HR (1) HRP20000859A2 (hr)
HU (1) HUP0102505A3 (hr)
ID (1) ID27599A (hr)
IL (1) IL138630A0 (hr)
IS (1) IS5691A (hr)
MA (1) MA26652A1 (hr)
NO (1) NO20006312D0 (hr)
OA (1) OA11505A (hr)
PA (1) PA8475901A1 (hr)
PE (1) PE20000646A1 (hr)
PL (1) PL344981A1 (hr)
SK (1) SK18912000A3 (hr)
TN (1) TNSN99124A1 (hr)
TR (1) TR200003544T2 (hr)
WO (1) WO1999065486A1 (hr)
ZA (1) ZA993975B (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
MXPA03001771A (es) * 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US7476653B2 (en) * 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
GT199900087A (es) 2000-12-07
JP2002518326A (ja) 2002-06-25
CN1301160A (zh) 2001-06-27
HUP0102505A3 (en) 2002-12-28
PL344981A1 (en) 2001-11-19
PA8475901A1 (es) 2000-05-24
BG105041A (en) 2001-08-31
PE20000646A1 (es) 2000-08-05
EA200001186A1 (ru) 2001-06-25
NO20006312L (no) 2000-12-12
CO5070587A1 (es) 2001-08-28
WO1999065486A1 (en) 1999-12-23
ID27599A (id) 2001-04-12
HN1999000097A (es) 1999-11-03
SK18912000A3 (sk) 2001-10-08
KR20010052852A (ko) 2001-06-25
TR200003544T2 (tr) 2001-04-20
AU4054799A (en) 2000-01-05
AP9901582A0 (en) 1999-06-30
TNSN99124A1 (fr) 2005-11-10
NO20006312D0 (no) 2000-12-12
HRP20000859A2 (en) 2001-04-30
MA26652A1 (fr) 2004-12-20
OA11505A (en) 2004-05-07
AR018869A1 (es) 2001-12-12
ZA993975B (en) 2000-12-15
CA2335134A1 (en) 1999-12-23
BR9911324A (pt) 2001-04-03
EP1087764A1 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
IS5386A (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
GB2361878B (en) Bone cement mixer and method
DK0881354T3 (da) Fremgangsmåde og apparat til cementering af en brønd
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
DE69837264D1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
AU6459000A (en) Method and apparatus for delivering cement to bones and/or positioning components
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
NO20020912L (no) Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter
DK1181397T3 (da) Rhodium-elektrokatalysator og fremgangsmåde til fremstilling af denne
NO20010468D0 (no) Anvendelse av biogene östrogensulfamater til hormonerstatningsterapi
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
IS5691A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva
DK3497A (da) Formulering med vedvarende frigivelse af et animalsk væksthormon og fremgangsmåde til fremstilling deraf
DK1131083T3 (da) Anvendelse af væksthormonfrigørende forbindelser og antagonister deraf til behandling af tumorer
DK0977736T3 (da) Fremgangsmåde til fremstilling af rent flupirtin-maleat og dettes modifikation A
IS5719A (is) Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni
DK0911303T3 (da) Fremgangsmåde og system til at styre blanding af råmaterialer til cement
DK0811324T3 (da) Fremgangsmåde og indretning til fremstilling af frosne sammensætninger indeholdende stykker
IS5727A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva
NO20011824D0 (no) Gjödningsblandinger med kontrollert frigjöring og fremgangsmåter for fremstilling derav
IL147008A0 (en) Mixing apparatus and method of mixing
DK0953291T3 (da) Fremgangsmåde og maskine til raffinering af konfektmateriale
AP9700913A0 (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regiments
NO20032021D0 (no) Fremgangsmåte og apparat til fremstilling av snö
DK1031565T3 (da) Hidtil ukendte krystaller af depsipeptidderivat og fremgangsmåde til fremstilling heraf